Caremark's

Those estimates do not include "up-selling" of CVS Caremark's products and services.

CVS Caremark Says Drug-Benefit Business Strong Dinah Wisenberg Brin 2010

The deal will crimp profit margins at first, but is expected to get better over time, a result of Caremark's aggressive overtures, which analysts say have been key to garnering all the new business.

CVS Profit at High End of Expectations Maxwell Murphy 2011

Gross business wins should contribute $9.8 billion to revenue next year, with $8.2 billion coming from CVS Caremark's new relationship with health insurer Aetna Inc., which recently contracted Caremark to administer its in-house PBM.

CVS Caremark Says Drug-Benefit Business Strong Dinah Wisenberg Brin 2010

CVS Caremark's health-plan clients can adopt this list, which includes alternative treatments in each case, or opt for a customized drug plan that consultants said could mean clients get a smaller share of the rebates CVS Caremark secures.

CVS Disfavors Some Drugs Jon Kamp 2011

Thursday's move comes as the FTC scrutinizes a proposed merger between Caremark's top two pharmacy-benefit rivals, Express Scripts Inc. and Medco Health Solutions Inc.

CVS Settles Deceptive Pricing Charges Brent Kendall 2012

"Last year was one of uncertainty and change for our clients as they worked to understand the impact of health-care reform while also dealing with a sluggish economic recovery," said Per Lofberg, president of CVS Caremark's pharmacy-benefit management business.

CVS: Use of Generics Kept Costs Down in 2010 Tess Stynes 2011

Lazard Capital Markets analyst Thomas Gallucci said Caremark's PBM selling season is "trending well," with some $500 million in net wins excluding the Aetna arrangement and new Medicare prescription-drug plan enrollments.

CVS Caremark Says Drug-Benefit Business Strong Dinah Wisenberg Brin 2010

"It is important to note that, at the conclusion of this comprehensive investigation, the FTC made no allegations of antitrust law violations or anticompetitive behavior associated with any of our business practices, products or service offerings," Douglas A. Sgarro , CVS Caremark's chief legal officer, said in a statement.

CVS Settles Deceptive Pricing Charges Brent Kendall 2012

The activity followed an announcement from Walgreen, which said it was dropping out of CVS's drug-benefits network, citing a decision by CVS to promote prescription plans that required patients with chronic conditions to use CVS stores or Caremark's mail-order pharmacy.

Traders Pick Sides as Walgreen, CVS Face Off 2010

If Walgreen's and CVS don't reach an understanding, the biggest winners will likely be Caremark's rival pharmacy-benefit managers, particularly

Walgreen Cuts Ties With CVS Caremark Plans 2010